Pragma Bio
Pre-clinicalPragma Bio’s AI-enabled biology-first approach mines an untapped clinically-relevant source of novel small molecules to target the gut-immune axis for diverse clinical applications.
Founded
2021
Focus
MicrobiomeSmall Molecules
About
Pragma Bio’s AI-enabled biology-first approach mines an untapped clinically-relevant source of novel small molecules to target the gut-immune axis for diverse clinical applications.
Funding History
2Total raised: $26.2M
Series A$22MUndisclosedOct 15, 2023
Seed$4.2MUndisclosedJan 15, 2022
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile